Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,055 public trials 716 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Active, not recruiting

Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana

NCT01386801

Conditions
Diabetes Mellitus, Diabetes Mellitus Type II, Diabetes Mellitus, Type 2, +4 more
Locations
  • American Health Network Avon, Indiana, United States
  • Investigator's Research Group Brownsburg, Indiana, United States
  • American Health Network Franklin, Indiana, United States
  • American Health Network Greenfield, Indiana, United States
View Trial Details
Completed

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

NCT06797869

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetic Peripheral Neuropathy, +4 more
Locations
  • eStudySite La Mesa, California, United States
  • Linda Vista Health Care Ctr San Diego, California, United States
  • My Preferred Research Miami, Florida, United States
  • New Horizon Research Center Miami, Florida, United States
View all 55 locations
View Trial Details
Completed

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

NCT06926842

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +11 more
Locations
  • Cullman Clinical Trials - Family Medicine Cullman, Alabama, United States
  • AZ Endocrine Institute Chandler, Arizona, United States
  • Elite Clinical Studies, LLC Phoenix, Arizona, United States
  • M3 Wake Research, Tucson Neuroscience Research, LLC Tucson, Arizona, United States
View all 48 locations
View Trial Details
Completed

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin

NCT06323161

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Valley Clinical Trials, Inc. Northridge, California, United States
  • Bioclinical Research Alliance Miami, Florida, United States
  • Solaris Clinical Research Meridian, Idaho, United States
  • Iowa Diab & Endo Res Center West Des Moines, Iowa, United States
View all 61 locations
View Trial Details
Completed

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

NCT05232071

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +8 more
Locations
  • Birmingham Digestive Health Research Homewood, Alabama, United States
  • Institute for Liver Health dba Arizona Liver Health Chandler, Arizona, United States
  • ARcare Center for Clinical Research Conway, Arkansas, United States
  • ARcare Center for Clinical Research Little Rock, Arkansas, United States
View all 42 locations
View Trial Details
Completed

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

NCT06534411

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Cahaba Research Pelham, Alabama, United States
  • Velocity Clinical Research-Phoenix Phoenix, Arizona, United States
  • AES Tucson DRS Tucson, Arizona, United States
  • Woodland Int. Research Group Little Rock, Arkansas, United States
View all 163 locations
View Trial Details

Related conditions